RELA fusion-positive anaplastic ependymoma: molecular characterization and advanced MR imaging

  • Shumpei Onishi
  • Fumiyuki Yamasaki
  • Yoshiko Nakano
  • Takeshi Takayasu
  • Vishwa Jeet Amatya
  • Manish Kolakshyapati
  • Yukio Takeshima
  • Takanori Hirose
  • Koichi Ichimura
  • Kazuhiko Sugiyama
  • Kaoru Kurisu
Letter to the Editor

Notes

Acknowledgements

The authors thank Japan Children’s Cancer Group for providing a central diagnostic service supported by the Practical Research for Innovative Cancer Control from Japan Agency for Medical Research and development, AMED.

Compliance with ethical standards

Conflict of interest

The authors declare that they have no conflict of interest.

References

  1. 1.
    Ellison DW, Kocak M, Figarella-Branger D et al (2011) Histopathological grading of pediatric ependymoma: reproducibility and clinical relevance in European trial cohorts. J Negat Results Biomed 10:7. doi: 10.1186/1477-5751-10-7 CrossRefPubMedPubMedCentralGoogle Scholar
  2. 2.
    Pajtler KW, Witt H, Sill M et al (2015) Molecular classification of ependymal tumors across All CNS compartments, histopathological grades, and age groups. Cancer Cell 27:728–743. doi: 10.1016/j.ccell.2015.04.002 CrossRefPubMedPubMedCentralGoogle Scholar
  3. 3.
    Louis DN, Perry A, Reifenberger G et al (2016) The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary. Acta Neuropathol 131:803–820. doi: 10.1007/s00401-016-1545-1 CrossRefPubMedGoogle Scholar
  4. 4.
    Kralik SF, Taha A, Kamer AP et al (2014) Diffusion imaging for tumor grading of supratentorial brain tumors in the first year of life. AJNR Am J Neuroradiol 35:815–823. doi: 10.3174/ajnr.A3757 CrossRefPubMedGoogle Scholar
  5. 5.
    Yamasaki F, Kurisu K, Satoh K et al (2005) Apparent diffusion coefficient of human brain tumors at MR imaging. Radiology 235:985–991. doi: 10.1148/radiol.2353031338 CrossRefPubMedGoogle Scholar
  6. 6.
    Parker M, Mohankumar KM, Punchihewa C et al (2014) C11orf95-RELA fusions drive oncogenic NF-κB signalling in ependymoma. Nature 506:1–16. doi: 10.1038/nature13109 CrossRefGoogle Scholar
  7. 7.
    Kiefel H, Bondong S, Hazin J et al (2012) L1CAM: a major driver for tumor cell invasion and motility. Cell Adh Migr 6:374–384. doi: 10.4161/cam.20832 CrossRefPubMedPubMedCentralGoogle Scholar
  8. 8.
    Merchant TE, Fouladi M (2005) Ependymoma: new therapeutic approaches including radiation and chemotherapy. J Neurooncol 75:287–299. doi: 10.1007/s11060-005-6753-9 CrossRefPubMedGoogle Scholar
  9. 9.
    Yamasaki F, Takayasu T, Nosaka R et al (2017) Development of cystic malacia after high-dose cranial irradiation of pediatric CNS tumors in long-term follow-up. Childs Nerv Syst 33:957–964. doi: 10.1007/s00381-017-3400-7 CrossRefPubMedGoogle Scholar
  10. 10.
    Takizawa D, Mizumoto M, Yamamoto T et al (2017) A comparative study of dose distribution of PBT, 3D-CRT and IMRT for pediatric brain tumors. Radiat Oncol 12:40. doi: 10.1186/s13014-017-0775-2 CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© The Japan Society of Brain Tumor Pathology 2017

Authors and Affiliations

  • Shumpei Onishi
    • 1
    • 2
  • Fumiyuki Yamasaki
    • 1
  • Yoshiko Nakano
    • 6
  • Takeshi Takayasu
    • 1
  • Vishwa Jeet Amatya
    • 3
  • Manish Kolakshyapati
    • 1
  • Yukio Takeshima
    • 3
  • Takanori Hirose
    • 4
  • Koichi Ichimura
    • 6
  • Kazuhiko Sugiyama
    • 5
  • Kaoru Kurisu
    • 1
  1. 1.Department of Neurosurgery, Graduate School of Biomedical and Health SciencesHiroshima UniversityHiroshima-CityJapan
  2. 2.Department of NeurosurgeryHigashihiroshima Medical CenterHiroshimaJapan
  3. 3.Department of Pathology, Graduate School of Biomedical and Health SciencesHiroshima UniversityHiroshimaJapan
  4. 4.Pathology for Regional CommunicationKobe University School of MedicineHyogoJapan
  5. 5.Department of Clinical Oncology and Neuro-oncology ProgramHiroshima University HospitalHiroshimaJapan
  6. 6.Division of Brain Tumor Translational ResearchNational Cancer Center Research InstituteTokyoJapan

Personalised recommendations